Mutation of regulatory phosphorylation sites in PFKFB2 does not affect the anti-fibrotic effect of metformin in the kidney
Geoff Harley(Austin Health), David A. Power(Austin Hospital)
Cited by 3
Related Papers
Deficiency in Apoptosis-Inducing Factor Recapitulates Chronic Kidney Disease via Aberrant Mitochondrial Homeostasis
|Diabetes|2016|57
Mutation of regulatory phosphorylation sites in PFKFB2 worsens renal fibrosis
|Scientific Reports|2020|26
Activation of AMPK reduces the co-transporter activity of NKCC1
|Molecular Membrane Biology|2014|11